checkAd
    Startseite > Aktien > Clearside Biomedical > Nachrichten
    Clearside Biomedical Aktie
    1,3400
     
    USD
    +6,35 %
    +0,0800 USD
    Letzter Kurs 02:00:00 Nasdaq
    1,3000
     
    USD
    1.300 STK
    Geldkurs 26.04.24
    1,3400
     
    USD
    7.600 STK
    Briefkurs 26.04.24
    ISIN: US1850631045 · WKN: A2ALP6 · SYM: CLSD · USA

    Neueste Nachrichten

    Clearside Biomedical Appoints Seasoned Biotechnology Executive Anthony S. Gibney to its Board of Directors
    16.04.24 · globenewswire · Clearside Biomedical
    Clearside Biomedical to Participate in Fireside Chat at the 23rd Annual Needham Virtual Healthcare Conference
    02.04.24 · globenewswire · Clearside Biomedical
    Clearside Biomedical Appoints Victor Chong, M.D., MBA as Chief Medical Officer
    18.03.24 · globenewswire · Clearside Biomedical
    Clearside Biomedical Announces Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update
    12.03.24 · globenewswire · Clearside Biomedical
    Clearside Biomedical to Report Fourth Quarter and Full Year 2023 Financial Results and Provide Corporate Update on Tuesday, March 12, 2024
    29.02.24 · globenewswire · Clearside Biomedical
    Clearside Biomedical Announces Pricing of $15 Million Registered Direct Offering
    07.02.24 · globenewswire · Clearside Biomedical
    Clearside Biomedical Announces Third Quarter 2023 Financial Results and Provides Corporate Update
    13.11.23 · globenewswire · Clearside Biomedical
    Clearside Biomedical to Participate in Fireside Chat at the Stifel 2023 Healthcare Conference
    08.11.23 · globenewswire · Clearside Biomedical
    Clearside Biomedical’s Versatile Suprachoroidal Injection Platform Highlighted in Four Ophthalmic Indications in Clinical Data Presentations at AAO 2023 Annual Meeting
    07.11.23 · globenewswire · Clearside Biomedical
    Clearside Biomedical Announces Presentations at the American Academy of Ophthalmology 2023 Annual Meeting
    02.11.23 · globenewswire · Clearside Biomedical
    Clearside Biomedical Completes Recruitment in ODYSSEY Phase 2b Clinical Trial of CLS-AX in Wet AMD
    01.11.23 · globenewswire · Clearside Biomedical
    Clearside Biomedical to Report Third Quarter 2023 Financial Results and Provide Corporate Update on Monday, November 13, 2023
    31.10.23 · globenewswire · Clearside Biomedical